First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank(Heidelberg University), Christoph Markert(University Hospital Heidelberg), Nicolas Hohmann(Heidelberg University), Alexandra Carls(Heidelberg University), Gerd Mikus(Heidelberg University), Thorsten Lehr(Saarland University), Alexander I. Alexandrov, Mathias Haag(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Matthias Schwab(German Center for Infection Research), Stephan Urban(University Hospital Heidelberg), Walter E. Haefeli(University Hospital Heidelberg)
Cited by 218
Abstract
Related Papers
No related papers found
Powered by citation graph analysis